SDP Japan develops integrated surgical-care platforms that help partner medical institutions with patient acquisition, supply procurement, real estate and medical equipment sourcing, and administrative operations. The company focuses on establishing and expanding specialty surgical institutions in orthopedics and cardiovascular care, primarily having produced seven surgery-focused facilities in the Tokyo metropolitan area. Its supported facilities performed over 3,000 surgeries in 2024, bringing cumulative procedures to approximately 14,000, and rank third in Tokyo for arrhythmia and hip joint replacement volumes. SDP Japan positions its model as a Japan-specific analogue to ASCs/HOPDs used internationally, aiming to realign acute care within Japan’s public insurance system. The company plans to use the new capital to strengthen its growth platform, roll out advanced surgical-care models nationwide, and rebuild medical infrastructure in regional cities to reduce disparities in access to care. The business case is supported by demographic trends: rising surgical demand in orthopedics and cardiovascular specialties (projected 5–8% annual growth) driven by Japan’s super-aging society.

Total raised

$30M

Funding rounds

1

Latest round

Series D

Latest activity

Jun 2025